Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Diagn Microbiol Infect Dis. 2013 Apr;75(4):426-30. doi: 10.1016/j.diagmicrobio.2012.12.014. Epub 2013 Feb 14.
Respiratory syncytial virus (RSV) is a serious cause of morbidity and mortality in the adult hematopoietic stem cell transplant (HSCT) population. The timely diagnosis of RSV infection in this population is important for initiating therapy and instituting appropriate infection prevention measures. Molecular multiplex assays now offer increased sensitivity for a more accurate diagnosis. This study presents 5 cases of RSV infection in HSCT patients in which diagnosis was delayed due to false-negative results from a multiplex polymerase chain reaction (PCR) assay. The false-negative result was due to a single base-pair mutation in the RSV strain. These false results delayed the appropriate treatment of patients. This study shows that a combination of a multiplex PCR assay, viral antigen, and/or culture should be used to detect variants of RSV in patients and that multiplex respiratory viral assays should develop a more robust design that includes multiple genetic target per virus to prevent missing viruses that continue to have genetic variances.
呼吸道合胞病毒(RSV)是成人造血干细胞移植(HSCT)人群发病率和死亡率的严重原因。及时诊断该人群的 RSV 感染对于开始治疗和实施适当的感染预防措施很重要。分子多重检测现在提供了更高的灵敏度,以更准确地诊断。本研究介绍了 5 例 HSCT 患者的 RSV 感染,由于多重聚合酶链反应(PCR)检测的假阴性结果,导致诊断延迟。假阴性结果是由于 RSV 株的单个碱基对突变。这些错误的结果延迟了对患者的适当治疗。本研究表明,应结合使用多重 PCR 检测、病毒抗原和/或培养来检测患者中 RSV 的变体,并且多重呼吸道病毒检测应开发更强大的设计,每个病毒包含多个遗传靶标,以防止继续具有遗传差异的病毒漏检。